HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)

被引：0
|
作者：
Ontiveros, Priscilla [1 ]
Landaverde, Connie [1 ]
Levin, Maren K. [2 ]
Hippely, Sarah [2 ]
Landers, Mark [1 ]
Wang, Yipeng [1 ]
Dittamore, Ryan [1 ]
O'Shaughnessy, Joyce A. [2 ]
机构：
[1] Epic Sci, San Diego, CA USA
[2] Baylor Scott & White Res Inst, Dallas, TX USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
457
引用
收藏
页数：2
相关论文
共 50 条
  • [21] HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
    Afroditi Nanou
    Leonie Laura Zeune
    Francois-Clement Bidard
    Jean-Yves Pierga
    Leonardus Wendelinus Mathias Marie Terstappen
    Breast Cancer Research, 22
  • [22] HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
    Nanou, Afroditi
    Zeune, Leonie Laura
    Bidard, Francois-Clement
    Pierga, Jean-Yves
    Terstappen, Leonardus Wendelinus Mathias Marie
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [23] HER2 expression on tumor-derived extracellular vesicles and circulating tumor cells in metastatic breast cancer
    Nanou, Afroditi
    Zeune, Leonie L.
    Bidard, Francois-Clement
    Pierga, Jean-Yves
    Terstappen, Leonardus W.
    CANCER RESEARCH, 2020, 80 (16)
  • [24] Distribution and prognostic significance of circulating tumor cells (CTCs) and tumor-derived extracellular vesicles (tdEVs) in patients (pts) with lobular metastatic breast cancer (MBC)
    Nicolo, Eleonora
    Gerratana, Lorenzo
    Foffano, Lorenzo
    Munoz-Arcos, Laura
    Serafini, Mara S.
    Manai, Maroua
    Pontolillo, Letizia
    Bayou, Nadia
    Molteni, Elisabetta
    Strickland, Amanda K.
    Gianni, Caterina
    Zhang, Youbin
    D'Amico, Paolo
    Davis, Andrew A.
    Donahue, Jeannine
    Liu, Huiping
    Gradishar, William J.
    Shah, Ami N.
    Curigliano, Giuseppe
    Reduzzi, Carolina
    Cristofanilli, Massimo
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Metastatic patterns and outcomes by HER2 and hormone receptor (HR) status in patients (pts) with metastatic breast cancer (mBC)
    Yuan, Qianyu
    Castellanos, Emily
    Fidyk, Erin
    Schwed, Karen
    Estevez, Melissa
    Nemeth, Sheila
    Linzmayer, Robin
    Cohen, Aaron B.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Prospective evaluation of serum HER2 in comparison with HER2 expression on circulating tumor cells in metastatic breast cancer patients as part of the DETECT study
    Mueller, V.
    Riethdorf, S.
    Rack, B.
    Janni, W.
    Fasching, P.
    Gebauer, G.
    Solomayer, E.
    Aktas, B.
    Zeitz, J.
    Kasimir-Bauer, S.
    Fehm, T.
    ONKOLOGIE, 2010, 33 : 19 - 19
  • [27] PIK3CA MUTATIONS AND LOSS OF PTEN EXPRESSION IN CIRCULATING TUMOR CELLS (CTCS) IN PATIENTS WITH METASTATIC BREAST CANCER (MBC)
    Lozano Mejorada, R.
    Matos, I.
    Marcos, R. A.
    Alfonso, S.
    Guillen, C.
    Noguerido, A.
    Rua, O.
    Vidal, R.
    Hernandez, M. A.
    Garcia, J. L.
    Gomez Bernal, A.
    Rodriguez, C. A.
    Cruz Hernandez, J. J.
    ANNALS OF ONCOLOGY, 2014, 25
  • [28] RANK expression in circulating tumor cells (CTCs): clinical utility in monitoring metastatic breast cancer patients (MBC) under denosumab treatment
    Zamarchi, R.
    Facchinetti, A.
    Rossi, E.
    Zoccoli, A.
    Iuliani, M.
    Pantano, F.
    Vincenzi, B.
    Tonini, G.
    Santini, D.
    CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (03) : 170 - 170
  • [29] Isolation of Highly Pure Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer (MBC) Patients for Gene Expression Analysis.
    Magbanua, M. J.
    Hauranieh, L.
    Pendyala, P.
    Sosa, E.
    Scott, J.
    Rugo, H.
    Park, J.
    CANCER RESEARCH, 2011, 71
  • [30] HER2 TUMOR HETEROGENEITY AND DISCREPANCIES IN HER2 STATUS BETWEEN PRIMARY TUMOR AND CORRESPONDING CIRCULATING TUMOR CELLS IN METASTATIC BREAST CANCER PATIENTS
    Migliaccio, I.
    Galardi, F.
    Bessi, S.
    Capaccioli, G.
    Biagioni, C.
    Truglia, M.
    Santarpia, L.
    Giannini, A.
    Di Leo, A.
    Pestrin, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 25 - 25
12345